# Moderna, Merck say mRNA treatment cuts melanoma recurrence, spread risk

https://mins.news/en/video/27354

- CNA, 2026-08-20 13:35 UTC
- Health
- Original: https://www.youtube.com/watch?v=xFZCvUslY1g

> US pharmaceutical giants Moderna and Merck say their vaccine reduced the risk that melanoma would return or spread. The companies describe it as the first mRNA-based cancer therapy to post positive results in a final-stage trial, raising hopes it could help patients with the deadliest form of skin cancer live longer.

## Related coverage

- ['Breakthrough' mRNA cancer drug curbs melanoma in large trial](https://mins.news/en/item/28210) — France 24, 2026-08-21
- [Why this mRNA cancer vaccine is raising new treatment hope](https://mins.news/en/video/26783) — Reuters, 2026-08-20
- [Moderna and Merck Revive mRNA Hopes With Melanoma Trial Success](https://mins.news/en/item/26437) — Bloomberg News, 2026-08-19
- [Merck, Moderna Melanoma Vaccine Study Succeeds](https://mins.news/en/video/26246) — Bloomberg Television, 2026-08-19
- [Moderna-Merck combination succeeds in late-stage skin cancer trial](https://mins.news/en/item/26142) — CNN, 2026-08-19